11-17356849-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001202439.3(NCR3LG1):c.269G>A(p.Arg90Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000521 in 1,536,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001202439.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NCR3LG1 | NM_001202439.3 | c.269G>A | p.Arg90Gln | missense_variant | 2/5 | ENST00000338965.9 | |
NCR3LG1 | XM_047426906.1 | c.269G>A | p.Arg90Gln | missense_variant | 2/6 | ||
NCR3LG1 | XM_011520074.4 | c.182G>A | p.Arg61Gln | missense_variant | 2/5 | ||
NCR3LG1 | XM_011520075.4 | c.182G>A | p.Arg61Gln | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NCR3LG1 | ENST00000338965.9 | c.269G>A | p.Arg90Gln | missense_variant | 2/5 | 1 | NM_001202439.3 | P1 | |
NCR3LG1 | ENST00000530403.1 | c.269G>A | p.Arg90Gln | missense_variant, NMD_transcript_variant | 2/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000717 AC: 1AN: 139512Hom.: 0 AF XY: 0.0000132 AC XY: 1AN XY: 75628
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1383818Hom.: 0 Cov.: 31 AF XY: 0.00000439 AC XY: 3AN XY: 682844
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2023 | The c.269G>A (p.R90Q) alteration is located in exon 2 (coding exon 2) of the NCR3LG1 gene. This alteration results from a G to A substitution at nucleotide position 269, causing the arginine (R) at amino acid position 90 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at